These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 32294396)
1. Effect of Natesto on Reproductive Hormones, Semen Parameters and Hypogonadal Symptoms: A Single Center, Open Label, Single Arm Trial. Ramasamy R; Masterson TA; Best JC; Bitran J; Ibrahim E; Molina M; Kaiser UB; Miao F; Reis IM J Urol; 2020 Sep; 204(3):557-563. PubMed ID: 32294396 [TBL] [Abstract][Full Text] [Related]
2. Converting Men From Clomiphene Citrate to Natesto for Hypogonadism Improves Libido, Maintains Semen Parameters, and Reduces Estradiol. Kavoussi PK; Machen GL; Gilkey MS; Chen SH; Kavoussi KM; Esqueda A; Wininger JD; Barsky M; Kavoussi SK Urology; 2021 Feb; 148():141-144. PubMed ID: 33301741 [TBL] [Abstract][Full Text] [Related]
3. Direct conversion from long-acting testosterone replacement therapy to Natesto allows for spermatogenesis resumption: Proof of concept. Kavoussi PK; Machen GL; Chen SH; Gilkey MS; Chen J; Hamzeh Y; Aston KI; Kavoussi SK Andrologia; 2022 Sep; 54(8):e14453. PubMed ID: 35521891 [TBL] [Abstract][Full Text] [Related]
5. Oral enclomiphene citrate stimulates the endogenous production of testosterone and sperm counts in men with low testosterone: comparison with testosterone gel. Kaminetsky J; Werner M; Fontenot G; Wiehle RD J Sex Med; 2013 Jun; 10(6):1628-35. PubMed ID: 23530575 [TBL] [Abstract][Full Text] [Related]
6. Men Converting from Clomiphene Citrate to Natesto with a Desire to Maintain Spermatogenesis Should Be Followed Closely. Kavoussi PK Urology; 2021 Nov; 157():128-130. PubMed ID: 34474044 [TBL] [Abstract][Full Text] [Related]
7. Sperm Count and Hypogonadism as Markers of General Male Health. Ferlin A; Garolla A; Ghezzi M; Selice R; Palego P; Caretta N; Di Mambro A; Valente U; De Rocco Ponce M; Dipresa S; Sartori L; Plebani M; Foresta C Eur Urol Focus; 2021 Jan; 7(1):205-213. PubMed ID: 31427194 [TBL] [Abstract][Full Text] [Related]
8. Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men, unlike topical testosterone: restoration instead of replacement. Kim ED; McCullough A; Kaminetsky J BJU Int; 2016 Apr; 117(4):677-85. PubMed ID: 26496621 [TBL] [Abstract][Full Text] [Related]
9. Testosterone nasal gel (Natesto) for hypogonadism. Med Lett Drugs Ther; 2015 May; 57(1468):73-4. PubMed ID: 25941957 [TBL] [Abstract][Full Text] [Related]
10. Body mass index in relation to semen quality and reproductive hormones in New Zealand men: a cross-sectional study in fertility clinics. Macdonald AA; Stewart AW; Farquhar CM Hum Reprod; 2013 Dec; 28(12):3178-87. PubMed ID: 24129611 [TBL] [Abstract][Full Text] [Related]
11. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate. Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948 [TBL] [Abstract][Full Text] [Related]
12. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels. Blick G Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769 [TBL] [Abstract][Full Text] [Related]
13. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production. Matsumoto AM J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626 [TBL] [Abstract][Full Text] [Related]
14. Natesto Effects on Reproductive Hormones and Semen Parameters: Results from an Ongoing Single-center, Investigator-initiated Phase IV Clinical Trial. Masterson T; Molina M; Ibrahim E; Ramasamy R Eur Urol Focus; 2018 Apr; 4(3):333-335. PubMed ID: 30177402 [TBL] [Abstract][Full Text] [Related]
15. Long-term efficacy and safety of a permeation-enhanced testosterone transdermal system in hypogonadal men. Arver S; Dobs AS; Meikle AW; Caramelli KE; Rajaram L; Sanders SW; Mazer NA Clin Endocrinol (Oxf); 1997 Dec; 47(6):727-37. PubMed ID: 9497881 [TBL] [Abstract][Full Text] [Related]
16. Influence of testosterone gel treatment on spermatogenesis in men with hypogonadism. George M; Yulia T; Svetlana K Gynecol Endocrinol; 2014 Oct; 30 Suppl 1():22-4. PubMed ID: 25200823 [TBL] [Abstract][Full Text] [Related]
17. Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy. Hsieh TC; Pastuszak AW; Hwang K; Lipshultz LI J Urol; 2013 Feb; 189(2):647-50. PubMed ID: 23260550 [TBL] [Abstract][Full Text] [Related]
18. Reversible infertility associated with testosterone therapy for symptomatic hypogonadism in infertile couple. Bang JK; Lim JJ; Choi J; Won HJ; Yoon TK; Hong JY; Park DS; Song SH Yonsei Med J; 2013 May; 54(3):702-6. PubMed ID: 23549818 [TBL] [Abstract][Full Text] [Related]